IconicAlpha
← Back to the wall
Eli Lilly and Co

Eli Lilly and Co

LLY · Healthcare · Pharmaceuticals

Market cap
$1149.55B
Price
$1216.92
Daily change
-0.31%
Rank
#10

Updated 24 min ago · data delayed ≥15 min

Iconic Score

Proprietary
78/ 100
Scale83
Momentum48
Sector leadership100

Ranked #9 of 503 by Iconic Score · #1 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a blend of scale, market attention, and category leadership.

Iconic Profile

Eli Lilly and Co (LLY) is a leading global pharmaceutical company specializing in the discovery, development, and commercialization of innovative medicines across various therapeutic areas, including diabetes, oncology, immunology, and neurodegeneration. With a market capitalization of $1119.3 billion, Lilly holds a strong position in the healthcare sector, driven by its robust pipeline of new drugs and a commitment to research and development. The company is recognized for its significant contributions to improving patient outcomes and addressing unmet medical needs, making it a key player in the pharmaceutical industry. Lilly's strategic focus on biopharmaceuticals and personalized medicine underscores its relevance in a rapidly evolving healthcare landscape, as it seeks to enhance the quality of life for patients worldwide.

Visit website ↗Compare ⇄Claim this profile

Enterprise tier: claim your logo to manage how your brand is represented.